Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Depress Anxiety. 2013 Feb 14;30(4):10.1002/da.22078. doi: 10.1002/da.22078

Synergistic Relationships Among Stress, Depression, and Troubled Relationships: Insights from Psychoneuroimmunology

Lisa M Jaremka a, Monica E Lindgren a, Janice K Kiecolt-Glaser a,b
PMCID: PMC3816362  NIHMSID: NIHMS520991  PMID: 23412999

Abstract

Stress and depression consistently elevate inflammation. Stress and depression are often experienced simultaneously, which is exemplified by people in troubled relationships. Troubled relationships also elevate inflammation, which may be partially explained by their ability to engender high levels of stress and depression. People who are stressed, depressed, or in troubled relationships are also at greater risk for health problems than their less distressed counterparts. Inflammation, a risk factor for a variety of age-related diseases including cardiovascular disease, Type II diabetes, metabolic syndrome, and frailty, may be one key mechanistic pathway linking distress to poor health. Obesity may further broaden the health implications of stress and depression; people who are stressed or depressed are often overweight, and adipose tissue is a major source of proinflammatory cytokines. Stress, depression, and troubled relationships may have synergistic inflammatory effects; loneliness, subclinical depression, and major depression enhance inflammatory responses to an acute stressful event. The relationship between distress and inflammation is bi-directional; depression enhances inflammation and inflammation promotes depression. Interesting questions emerge from this literature. For instance, some stressors may be more potent than others and thus may be more strongly linked to inflammation. In addition, it is possible that psychological and interpersonal resources may buffer the negative inflammatory effects of stress. Understanding the links among stress, depression, troubled relationships and inflammation is an exciting area of research that may provide mechanistic insight into the links between distress and poor health.


People who are stressed, depressed, or in troubled relationships are at greater risk for health problems than their less distressed counterparts.1 For example, major depression enhances risk for osteoporosis, metabolic syndrome, coronary heart disease, myocardial infarction, and premature all-cause mortality.26 Similarly, compared to their less stressed counterparts, chronically stressed people were more vulnerable to the common cold and had higher cardiovascular disease and myocardial infarction incidence rates.79 Troubled interpersonal relationships are also linked to multiple health problems including coronary heart disease, delayed wound healing, metabolic syndrome, and premature all-cause mortality.1013 Importantly, the links among stress, depression, troubled relationships, and health remain after controlling for important sociodemographic and health-relevant risk factors.

Growing evidence suggests that inflammation, a key component of the immune system’s response to injury or infection, may be one potential pathway linking stress, depression, and troubled relationships to poor health. Chronic inflammation increases risk for premature all-cause mortality and age-related diseases such as cardiovascular disease, Type II diabetes, metabolic syndrome, neurodegenerative disorders, and frailty.1417

In this review, we first discuss evidence that stress, depression, and troubled relationships elevate inflammation and briefly describe potential mechanistic pathways. Next, we examine the synergistic relationships among stress, depression, and troubled relationships and evaluate the clinical implications of distress-related inflammation. We also discuss evidence supporting the bi-directional relationship between distress and inflammation. We conclude by suggesting areas for future research. Throughout this review we focus on the empirical adult human literature and common inflammatory mediators such as C-reactive protein (CRP), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α).

Inflammation: A Biological Correlate of Stress, Depression, and Troubled Relationships

Both major depression and depressive symptoms elevate inflammation.18 For example, data from a meta-analysis demonstrated that people with major depression had higher IL-6 and TNF-α than those who were not depressed.19 In addition, a series of epidemiological studies demonstrated that older adults with more depressive symptoms had higher IL-6 than those with fewer symptoms.2023 Similarly, older adults with higher levels of depressive symptoms had larger IL-6 responses to an influenza vaccine immune-challenge than less depressed older adults.24 The links among inflammation and clinical and subclinical depression have been replicated in chronically ill populations including cancer survivors and acute coronary syndrome patients.2528

Stress reliably enhances inflammation in naturalist and laboratory contexts.2932 For example, students had higher inflammation levels, including stimulated IL-6 and IL-1β production, immediately after a stressful exam compared with a lower stress baseline period.3336 In addition, IL-6, interferon (IFN) -gamma, and other inflammatory markers were higher after a laboratory stressor (delivering an evaluated and timed speech) than before the stressor.3739

Lower socioeconomic status (SES), a chronic stressor, is also associated with elevated inflammation. Lower SES people are more stressed than their higher SES counterparts.40 In addition, chronic stresses such as restricted access to medical care, poor environmental conditions, and limited income are more commonly experienced by people with lower rather than higher SES.41 Lower SES, whether measured by personal or household income, social class, work position, financial assets, or education level, is linked to elevated inflammation.4252

Stress and depression are often experienced simultaneously,53 which is exemplified by people in troubled relationships. For example, troubled relationships are a reliable risk factor for both clinical and subclinical depression,5456 and people in unsupportive relationships are less resilient to stress than those with more supportive relationships.5759 Indeed, troubled relationships are often conceptualized as one form of chronic stress that also engenders major depression or depressive symptomology.56 Troubled relationships elevate inflammation, which may be partially explained by their ability to engender high levels of stress and depression.54,55

Observational studies of marital conflict discussions provide a unique window into the effects of troubled relationships on inflammation; behavioral coding systems assess actual relationship behaviors and thus do not rely on self-reported relationship quality. A provocative study using this paradigm demonstrated that wound healing, an inflammation-mediated event, was slower after a marital disagreement than a socially supportive discussion.11 In addition, production of inflammatory cytokines at the wound site was lower following the conflict than the support discussion. In contrast to systemic inflammation, which is linked to a variety of age-related diseases,15,17,60,61 local inflammation at the wound site is adaptive and critical to effective wound healing. These results show that marital conflict produces maladaptive immunological responses, as evidenced by differences in wound repair and cytokine production at the wound site.

Negative and hostile behaviors during a conflict discussion, such as blaming or interrupting the partner, appear to be particularly detrimental. A conflict discussion led to slower wound healing among couples displaying more hostile behaviors compared to those with fewer hostile behaviors.11 Furthermore, whereas hostile couples had higher systemic inflammation following a conflict discussion compared to a social support discussion, low hostile couples had similar levels of inflammation across both discussions.11

Loneliness, a state of perceived social isolation and interpersonal distress, also elevates inflammation. For instance, compared with people who felt more socially connected counterparts, those who felt lonelier had higher inflammation, up-regulated proinflammatory genes, and down-regulated anti-inflammatory genes.6264 A preliminary mindfulness-based stress intervention concurrently reduced loneliness and down-regulated proinflammatory gene transcription.63 Taken together, these studies provide further support that troubled and distressed relationships, in this case as experienced by lonely people, have negative inflammatory effects.

Family members providing care for a loved one with Alzheimer’s disease or a related dementia are, on average, more stressed, depressed, and lonely than noncaregivers.65,66 Thus, it is not surprising that multiple studies show elevated inflammation among caregivers. For example, dementia family caregivers had higher IL-6 and TNF-α than noncaregivers.6769

Stress, depression, and troubled relationships may also fuel longitudinal changes in inflammation over time, particularly among older adults. Indeed, more depressed older adults had larger IL-6 increases over 6 years than their less depressed counterparts.70 Similarly, IL-6 increases over a 6-year period were about four times as large among spousal dementia caregivers than noncaregivers.66 Furthermore, the IL-6 increases did not differ between current caregivers and former caregivers even several years after the death of the dementia patient. However, perceived stress and loneliness also did not differ between current and former caregivers, suggesting that psychological recovery from a stressor may be critical to reducing inflammation over time. Consistent with this possibility, people who recovered from an episode of major depression within the prior year continued to show higher levels of CRP compared with nondepressed controls.71,72 However, major depression is often followed by subclinical depressive symptoms, which may partially account for elevated inflammation after a depressive episode ends.

Stress, depression, and troubled relationships can influence inflammation through a variety of pathways. One common mechanism linking stress and depression to inflammation is health behaviors; people who are stressed or depressed often have poor health behaviors such as inactivity or smoking 73,74, and these health choices can elevate inflammation 48. Stress, depression, and troubled relationships also influence inflammation via the sympathetic and parasympathetic nervous systems. For example, stress activates the sympathetic nervous system, which causes the release of epinephrine and norepinephrine. In turn, these stress hormones stimulate the release of proinflammatory cytokines. A full review of mechanistic pathways is outside of the scope of this chapter; more detailed explanations are available elsewhere for the interested reader.7577

In sum, there is a large body of evidence demonstrating that stress, depression, and troubled relationships elevate inflammation. In addition, initial evidence suggests that stress and depression may fuel longitudinal increases in inflammation over time, especially among older adults. Inflammation is a risk factor for age-related diseases,14,15 suggesting one mechanistic pathway linking stress, depression, and troubled relationships to poor health.

Synergistic Relationships Among Stress, Depression, and Troubled Relationships

Stress, depression, and troubled relationships often occur simultaneously and may have synergistic effects on inflammatory responses.53,78 Initial evidence suggests that people who are highly distressed about a task may have an exaggerated inflammatory reaction to that task.35,79 For instance, people who were more anxious about an upcoming speech had higher post-speech IL-6 than those who were less anxious.80 In addition, students who perceived an exam as very stressful had higher levels of the soluble interleukin-6 receptor (sIL-6r) than those who perceived it as less stressful.81 Because sIL-6r potentiates the effects of IL-6 by increasing its inflammatory capabilities,82 the sIL-6r data suggest that stress may exacerbate inflammatory activity.

Depression and loneliness may also prime the immune system’s response to stressful events. For example, the stress of giving birth led to greater IL-6 increases among women with a history of major depression than those without a history of major depression.83 In addition, healthy adults with higher levels of depressive symptoms produced more IL-6 in response to an acute laboratory stressor than those with lower levels of depressive symptoms.84 Among healthy adults and post-treatment breast cancer survivors, inflammation was elevated after an acute laboratory stressor for those experiencing greater loneliness compared with those who were less lonely.64,85

In sum, stress, depression, and troubled relationships often occur simultaneously and mutually influence each other. The studies described above suggest that the combination of stressful events, depression, and troubled relationships may be fuel immune dysregulation, and thus may further elevate risk for health problems.86

Clinical Implications of Distress-Related Inflammation

Inflammation is related to both the incidence and prognosis for a number of chronic medical conditions, including cancer, metabolic syndrome, rheumatoid arthritis, neurodegenerative disorders, asthma, gingivitis, and cardiovascular disease.8791 In addition, stress and depression are highly prevalent among people with chronic medical conditions.92 Accordingly, stress and depression-related inflammation have clear clinical implications for the management of these chronic conditions. The broad literature addressing stress and depression among medical populations is beyond the scope of this review; we provide brief exemplars using two very different inflammatory conditions, gingivitis and cardiovascular disease. We also discuss how obesity may exacerbate the links among stress, depression, inflammation, and inflammatory diseases.

Stress and depression enhance risk for gingivitis, a mild periodontal disease characterized by inflamed gums.9396 For example, spousal dementia caregivers had more gingival symptoms than noncaregivers, which was explained, in part, by caregivers’ elevated stress and depressive symptoms.97 A series of studies further demonstrated that stress elevated specific inflammatory markers that promoted gingival symptoms, suggesting one pathway through which stress affected gingivitis. Interleukin-8 (IL-8), which initiates degradation of connective tissue at inflamed gingival sites, was higher in students’ gingival crevicular fluid (GCF) after delivering a videotaped and timed speech than after a control task.98 Similarly, adults who reported more socially-oriented stressful life events had higher IL-8 in their GCF than those who reported fewer events.99 IL-1β, a cytokine that hampers bone formation and fosters periodontal tissue destruction, was elevated in the GCF of students who took a stressful exam compared with those who did not take an exam.100 Furthermore, GCF IL-1β concentrations remained elevated two weeks after the exam ended,101 suggesting that stressful events may have longer-lasting prognostic potential for gingival symptoms.

There is a vast literature demonstrating that people who are highly stressed or depressed are more likely to develop cardiovascular disease and have worse disease-related outcomes than their less stressed or depressed counterparts.2,102,103 Furthermore, numerous studies have demonstrated that stress and depression elevate CRP and IL-6, two inflammatory markers that promote cardiovascular disease, suggesting one mechanism linking cardiovascular disease, stress, and depression.15,104 For instance, among women with suspected coronary ischemia, those with current depressive symptoms and a history of major depression had higher CRP and IL-6 and were more likely to develop cardiovascular disease than those who had neither.105 In addition, men with acute coronary syndrome (ACS) who had more depressive symptoms and higher levels of CRP experienced more adverse cardiac events than men with ACS who were less depressed and had lower levels of CRP.103

Obesity, a worldwide epidemic,106 may further broaden the clinical implications of stress and depression. People who are highly stressed or depressed are more likely to be overweight than their less stressed or depressed counterparts.107,108 Highly depressed people also experience greater increases in abdominal fat over time than those who are less depressed.109 In addition, abdominal adiposity (i.e., belly fat) is a major source of proinflammatory cytokines including IL-6, TNF-α, and IL-1β, 110,111 and is an important risk factor for a variety of diseases such as metabolic syndrome, Type II diabetes, and cardiovascular disease.112,113 Importantly, stress, depression, and obesity independently elevate inflammation.18,42 Thus, among people who are stressed or depressed, those who are also overweight are particularly at risk for elevated inflammation and inflammatory diseases.

Taken together, the gingivitis and cardiovascular disease findings suggest that stress and depression may exacerbate inflammatory diseases by elevating inflammatory markers that are implicated in risk of those diseases. Furthermore, the inflammatory effects of stress and depression are both local (as in the gingivitis studies) and systemic (as evidenced by the cardiovascular studies). Obesity may further exacerbate the relationships among stress, depression, and inflammation. Accordingly, distress-related inflammation has clinical implications for the management of inflammatory diseases.

The Bi-Directional Relationship between Distress and Inflammation

The relationship between depression and inflammation is bi-directional; depression enhances inflammation and inflammation promotes depression.114 Proinflammatory cytokine administration induces “sickness behaviors,” behavioral changes that resemble the somatic symptoms evident in depression, like anhedonia and lethargy.115 For example, both IL-6 and negative affect increased following a typhoid vaccine.116,117 In addition, depressed mood increased following an injection of endotoxin, bacterial toxins that provoke an inflammatory response.118,119 IFN-alpha (IFN-α) treatment results in symptoms consistent with major depression for a subset of people.120,121 Additional evidence suggests that IFN-α treatment-related depression produced more somatic depressive symptoms than traditional major depression,122 at least during the initial phase of treatment. Cognitive-affective symptoms appear to develop shortly thereafter and may be more responsive to antidepressant treatment.123,124 On the other hand, a TNF-α inhibiting medication improved psoriasis patients’ depressive symptoms, independent of disease improvement.125 Accordingly, research suggests that cytokine administration can promote depression, and anti-inflammatory medications may decrease depressive symptoms. Furthermore, immune-challenge paradigms are most clearly linked to depression-related somatic symptoms (e.g., “sickness behaviors); the effects of immune-challenge paradigms on the core cognitive-affective symptoms of depression, such as suicidal ideation and guilt, requires further examination.126

If stress and depression elevate inflammation, then treatments designed to reduce stress and depression should reduce inflammation. Consistent with this possibility, CRP decreased following antidepressant medication for a subset of people with major depressive disorder, although the anti-inflammatory effects of the medication were most reliable for those who benefited psychologically from treatment.127,128 People who do not benefit from antidepressants often have persistently higher IL-6 than those who do benefit, suggesting one potential way to identify people who will respond to antidepressants.114,127 Non-prescription pharmacological treatments may also improve depression and thus reduce inflammation. For example, growing evidence suggests that omega-3 fatty acids may have antidepressant effects.129,130 In addition, omega-3 supplementation reduces inflammation.131,132

Behavioral data further suggest that lowering distress reduces inflammation. For instance, a compassion meditation intervention reduced emotional distress and IL-6 for people who practiced more frequently than less frequently.133 In addition, the regular practice of yoga was related to lower baseline and stress-induced inflammation.134 Exercise also has well-documented anti-inflammatory and antidepressant effects.135,136 Some evidence eve suggests that exercise interventions may be as effective as antidepressive medications in alleviating major depression for some individuals.137

In sum, the relationship between distress and inflammation is bi-directional. Cytokine administration and other immune-challenge studies suggest that inflammation induces sickness behaviors such as anhedonia and lethargy. Studies demonstrating that depression interventions reduce inflammation support the argument that depression enhances inflammation.

Future Directions

Stress, depression, and troubled relationships reliably increase inflammation. However, it is possible that some stressors are more potent than others and are thus more strongly linked to inflammation. For example, loneliness threatens the need to belong, a fundamental need that is at the core of human nature, and thus should impact immune function across cultures and demographic groups.138,139 On the other hand, threats to social harmony are particularly relevant in Eastern cultures140 and thus may be more strongly related to inflammation among Eastern compared to Western cultures.

Stress and depressive symptoms often remain elevated after a stressful event ends.66,141 In addition, psychological recovery may be impacted by the length and intensity of the stressor, depressive episode, or troubled relationship. Accordingly, another intriguing question is how long inflammation remains elevated after a stressor ends and how this relates to psychological recovery. Furthermore, it is possible that older adults may be particularly influenced by the long-lasting inflammatory consequences of stress and depression.142

Depression and loneliness exacerbate stress-induced inflammation.84,85 However, some people may be more resilient in the face of stress than others. Indeed, psychological resources (e.g., self-esteem) and interpersonal resources (e.g., social support) may buffer the negative impacts of stress.143 For example, people with higher self-esteem perceived a timed and evaluated performance task as less stressful than those with lower self-esteem.144 In response to being told that a potential dating partner left the study early, higher self-esteem participants explained the other person’s behavior with more benign (e.g., the other participant was sick) than malevolent (e.g., the other participant did not like me) attributions.145 These studies suggest that, compared to their lower self-esteem counterparts, people with higher self-esteem may experience less stress in response to an objective stressor and may interpret ambiguous situations as less threatening. A novel new direction is to explore whether self-esteem differences in stress perceptions translate into altered stress-related inflammatory responses.

Researchers are beginning to understand the relationships between stress-induced health behaviors and inflammation. For example, people often eat poorly and stop exercising when they are stressed or depressed;73,146 both food and exercise influence inflammation.135,147 Researchers in these areas can investigate multiple hypotheses about the relationships among distress, health behaviors, and inflammation. For instance, stress and depression may affect inflammation because they cause poor health behaviors. Another possibility is that poor health behaviors exacerbate stress-induced inflammation.

Understanding the relationships between inflammation and interventions to reduce stress and depression is a burgeoning area of research.127,128,148 Because some people respond to behavioral and pharmacological treatments differently than other,127 exploring the relationship between psychological symptom improvement and decreased inflammation is important. Furthermore, the strongest evidence demonstrating that inflammation causes depression has focused on somatic symptoms (e.g., “sickness behaviors” like lethargy). Mechanistic insight may be gained if researchers can determine whether depression-related inflammatory changes are related to reduced “sickness behaviors,” cognitive-affective symptoms like suicidal ideation and guilt, or a combination of these factors.

In sum, research reliably demonstrates that inflammation is linked to stress, depression, and troubled relationships. Because elevated inflammation is a risk factor for poor health, 15,17,87,88,91 these studies may provide mechanistic insight into the ways that stress, depression, and troubled relationships affect health.

Acknowledgments

Work on this project was supported in part by an American Cancer Society Postdoctoral Fellowship Grant (121911-PF-12-040-01-CPPB), a Pelotonia Postdoctoral Fellowship from the Ohio State University Comprehensive Cancer Center, a National Cancer Institute Research Supplement to Promote Diversity in Health-Related Research (CA126857), and NIH Grants CA131029, CA126857, CA154054, and AG029562.

References

  • 1.Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annu Rev Psychol. 2002;53:83–107. doi: 10.1146/annurev.psych.53.100901.135217. [DOI] [PubMed] [Google Scholar]
  • 2.Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: Mechanisms of interaction. Biol Psychiatry. 2003;54(3):248–261. doi: 10.1016/s0006-3223(03)00568-7. [DOI] [PubMed] [Google Scholar]
  • 3.Michelson D, Stratakis C, Hill L, et al. Bone mineral density in women with depression. N Engl J Med. 1996;335(16):1176–1181. doi: 10.1056/NEJM199610173351602. [DOI] [PubMed] [Google Scholar]
  • 4.Pan A, Keum N, Okereke OI, et al. Bidirectional association between depression and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012;35(5):1171–1180. doi: 10.2337/dc11-2055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation. 1996;94(12):3123–3129. doi: 10.1161/01.cir.94.12.3123. [DOI] [PubMed] [Google Scholar]
  • 6.Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: The Cardiovascular Health Study. Arch Intern Med. 2000;160(12):1761–1768. doi: 10.1001/archinte.160.12.1761. [DOI] [PubMed] [Google Scholar]
  • 7.Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991;325(9):606–612. doi: 10.1056/NEJM199108293250903. [DOI] [PubMed] [Google Scholar]
  • 8.Kuper H, Marmot M. Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study. J Epidemiol Community Health. 2003;57(2):147–153. doi: 10.1136/jech.57.2.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Theorell T, Tsutsumi A, Hallquist J, et al. Decision latitude, job strain, and myocardial infarction: A study of working men in Stockholm. The SHEEP Study Group. Stockholm Heart epidemiology Program. Am J Public Health. 1998;88(3):382–388. doi: 10.2105/ajph.88.3.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: A meta-analytic review. PLoS Med. 2010;7(7):e1000316. doi: 10.1371/journal.pmed.1000316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kiecolt-Glaser JK, Loving TJ, Stowell JR, et al. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry. 2005;62(12):1377–1384. doi: 10.1001/archpsyc.62.12.1377. [DOI] [PubMed] [Google Scholar]
  • 12.Orth-Gomér K, Wamala SP, Horsten M, Schenck-Gustafsson K, Schneiderman N, Mittleman MA. Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study. JAMA. 2000;284(23):3008–3014. doi: 10.1001/jama.284.23.3008. [DOI] [PubMed] [Google Scholar]
  • 13.Whisman MA. Loneliness and the metabolic syndrome in a population-based sample of middle-aged and older adults. Health Psychol. 2010;29(5):550–554. doi: 10.1037/a0020760. [DOI] [PubMed] [Google Scholar]
  • 14.Ershler WB, Keller ET. Age-associated increased Interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51(1):245–270. doi: 10.1146/annurev.med.51.1.245. [DOI] [PubMed] [Google Scholar]
  • 15.Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine. 2005;352(16):1685–1695. doi: 10.1056/NEJMra043430. [DOI] [PubMed] [Google Scholar]
  • 16.Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and c-reactive protein levels with mortality in the elderly. The American Journal of Medicine. 1999;106(5):506–512. doi: 10.1016/s0002-9343(99)00066-2. [DOI] [PubMed] [Google Scholar]
  • 17.Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867. doi: 10.1038/nature05485. [DOI] [PubMed] [Google Scholar]
  • 18.Howren MB, Lamkin DM, Suls J. Associations of depression with c-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med. 2009;71(2):171–186. doi: 10.1097/PSY.0b013e3181907c1b. [DOI] [PubMed] [Google Scholar]
  • 19.Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi: 10.1016/j.biopsych.2009.09.033. [DOI] [PubMed] [Google Scholar]
  • 20.Bremmer MA, Beekman ATF, Deeg DJH, et al. Inflammatory markers in late-life depression: Results from a population-based study. J Affect Disord. 2008;106(3):249–255. doi: 10.1016/j.jad.2007.07.002. [DOI] [PubMed] [Google Scholar]
  • 21.Dentino AN, Pieper CF, Rao KMK, et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 1999;47(1):6–11. doi: 10.1111/j.1532-5415.1999.tb01894.x. [DOI] [PubMed] [Google Scholar]
  • 22.Penninx B, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: Results from the Health, Aging and Body Composition study. Biol Psychiatry. 2003;54(5):566–572. doi: 10.1016/s0006-3223(02)01811-5. [DOI] [PubMed] [Google Scholar]
  • 23.Tiemeier H, Hofman A, Van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MMB. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14(1):103–107. doi: 10.1097/00001648-200301000-00025. [DOI] [PubMed] [Google Scholar]
  • 24.Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry. 2003;60(10):1009–1014. doi: 10.1001/archpsyc.60.10.1009. [DOI] [PubMed] [Google Scholar]
  • 25.Jehn CF, Kuehnhardt D, Bartholomae A, et al. Biomarkers of depression in cancer patients. Cancer. 2006;107(11):2723–2729. doi: 10.1002/cncr.22294. [DOI] [PubMed] [Google Scholar]
  • 26.Miller GE, Freedland KE, Duntley S, Carney RM. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 2005;95(3):317–321. doi: 10.1016/j.amjcard.2004.09.026. [DOI] [PubMed] [Google Scholar]
  • 27.Musselman DL. Higher Than Normal Plasma Interleukin-6 Concentrations in Cancer Patients With Depression: Preliminary Findings. Am J Psychiat. 2001;158(8):1252–1257. doi: 10.1176/appi.ajp.158.8.1252. [DOI] [PubMed] [Google Scholar]
  • 28.Shimbo D, Rieckmann N, Paulino R, Davidson KW. Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome. Heart. 2006;92(9):1316–1318. doi: 10.1136/hrt.2005.075861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117(2):309–317. doi: 10.1046/j.1523-1747.2001.01373.x. [DOI] [PubMed] [Google Scholar]
  • 30.Brydon L, Edwards S, Jia H, et al. Psychological stress activates interleukin-1beta gene expression in human mononuclear cells. Brain Behav Immun. 2005;19(6):540–546. doi: 10.1016/j.bbi.2004.12.003. [DOI] [PubMed] [Google Scholar]
  • 31.Steptoe A, Willemsen G, Owen N, Flower L, Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci. 2001;101(2):185–192. [PubMed] [Google Scholar]
  • 32.Von Känel R, Kudielka BM, Preckel D, Hanebuth D, Fischer JE. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav Immun. 2006;20(1):40–48. doi: 10.1016/j.bbi.2005.03.013. [DOI] [PubMed] [Google Scholar]
  • 33.Dobbin JP, Harth M, McCain GA, Martin RA, Cousin K. Cytokine production and lymphocyte transformation during stress. Brain Behav Immun. 1991;5(4):339–348. doi: 10.1016/0889-1591(91)90029-a. [DOI] [PubMed] [Google Scholar]
  • 34.Dugué B, Leppänen E, Gräsbeck R, Benoit D, Esa L, Ralph G. The driving license examination as a stress model: Effects on blood picture, serum cortisol and the production of interleukins in man. Life Sci. 2001;68(14):1641–1647. doi: 10.1016/s0024-3205(01)00963-8. [DOI] [PubMed] [Google Scholar]
  • 35.Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998;10(4):313–318. doi: 10.1006/cyto.1997.0290. [DOI] [PubMed] [Google Scholar]
  • 36.Paik IH, Toh KY, Lee C, Kim JJ, Lee SJ. Psychological stress may induce increased humoral and decreased cellular immunity. Behav Med. 2000;26(3):139–141. doi: 10.1080/08964280009595761. [DOI] [PubMed] [Google Scholar]
  • 37.Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci US A. 2003;100(4):1920–1925. doi: 10.1073/pnas.0438019100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Buske-Kirschbaum A, Kern S, Ebrecht M, Hellhammer DH. Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain Behav Immun. 2007;21(1):92–99. doi: 10.1016/j.bbi.2006.03.006. [DOI] [PubMed] [Google Scholar]
  • 39.Goebel MU, Mills PJ, Irwin MR, Ziegler MG. Interleukin-6 and tumor necrosis factor-a production after acute psychological stress, exercise, and infused isoproterenol: Differential effects and pathways. Psychosom Med. 2000;62(4):591–598. doi: 10.1097/00006842-200007000-00019. [DOI] [PubMed] [Google Scholar]
  • 40.Cohen S, Doyle WJ, Baum A. Socioeconomic status is associated with stress hormones. Psychosom Med. 2006;68(3):414–420. doi: 10.1097/01.psy.0000221236.37158.b9. [DOI] [PubMed] [Google Scholar]
  • 41.Baum A, Garofalo JP, Yali AM. Socioeconomic status and chronic stress: Does stress account for SES effects on health? Annals of the New York Academy of Sciences. 1999;896(1):131–144. doi: 10.1111/j.1749-6632.1999.tb08111.x. [DOI] [PubMed] [Google Scholar]
  • 42.Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun. 2006;20(5):498–504. doi: 10.1016/j.bbi.2005.10.003. [DOI] [PubMed] [Google Scholar]
  • 43.Gruenewald TL, Cohen S, Matthews KA, Tracy R, Seeman TE. Association of socioeconomic status with inflammation markers in black and white men and women in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Social Science & Medicine. 2009;69(3):451–459. doi: 10.1016/j.socscimed.2009.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hemingway H, Shipley M, Mullen MJ, et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study) Am J Cardiol. 2003;92(8):984–987. doi: 10.1016/s0002-9149(03)00985-8. [DOI] [PubMed] [Google Scholar]
  • 45.Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health. 2003;57(9):730–733. doi: 10.1136/jech.57.9.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Koster A, Bosma H, Penninx BWJH, et al. Association of inflammatory markers with socioeconomic status. J Gerontol A Biol Sci Med Sci. 2006;61(3):284–290. doi: 10.1093/gerona/61.3.284. [DOI] [PubMed] [Google Scholar]
  • 47.Loucks EB, Sullivan LM, Hayes LJ, et al. Association of educational level with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2006;163(7):622–628. doi: 10.1093/aje/kwj076. [DOI] [PubMed] [Google Scholar]
  • 48.McDade TW, Hawkley LC, Cacioppo JT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: The Chicago Health, Aging, and Social Relations Study. Psychosom Med. 2006;68(3):376–381. doi: 10.1097/01.psy.0000221371.43607.64. [DOI] [PubMed] [Google Scholar]
  • 49.Owen N, Poulton T, Hay FC, Mohamed-Ali V, Steptoe A. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun. 2003;17(4):286–295. doi: 10.1016/s0889-1591(03)00058-8. [DOI] [PubMed] [Google Scholar]
  • 50.Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood. J Epidemiol Community Health. 2008;62(6):484–491. doi: 10.1136/jech.2006.054106. [DOI] [PubMed] [Google Scholar]
  • 51.Ranjit N, Diez-Roux AV, Shea S, Cushman M, Ni H, Seeman T. Socioeconomic position, race/ethnicity, and inflammation in the Multi-Ethnic Study of Atherosclerosis. Circulation. 2007;116(21):2383–2390. doi: 10.1161/CIRCULATIONAHA.107.706226. [DOI] [PubMed] [Google Scholar]
  • 52.Steptoe A, Owen N, Kunz-Ebrecht S, Mohamed-Ali V. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav Immun. 2002;16(6):774–784. doi: 10.1016/s0889-1591(02)00030-2. [DOI] [PubMed] [Google Scholar]
  • 53.Hammen C. Stress and Depression. Annual Review of Clinical Psychology. 2005;1(1):293–319. doi: 10.1146/annurev.clinpsy.1.102803.143938. [DOI] [PubMed] [Google Scholar]
  • 54.Beach SRH, Fincham FD, Katz J. Marital therapy in the treatment of depression: Toward a third generation of therapy and research. Clin Psychol Rev. 1998;18(6):635–661. doi: 10.1016/s0272-7358(98)00023-3. [DOI] [PubMed] [Google Scholar]
  • 55.Cacioppo JT, Hawkley LC, Thisted RA. Perceived social isolation makes me sad: 5-year cross-lagged analyses of loneliness and depressive symptomatology in the Chicago Health, Aging, and Social Relations Study. Psychol Aging. 2010;25(2):453–463. doi: 10.1037/a0017216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kiecolt-Glaser JK, Newton TL. Marriage and health: His and hers. Psychological Bulletin. 2001;127(4):472–503. doi: 10.1037/0033-2909.127.4.472. [DOI] [PubMed] [Google Scholar]
  • 57.Cohen S, Hoberman HM. Positive events and social supports as buffers of life change stress. Journal of Applied Social Psychology. 1983;13(2):99–125. [Google Scholar]
  • 58.Ozbay F, Fitterling H, Charney D, Southwick S. Social support and resilience to stress across the life span: A neurobiologic framework. Curr Psychiatry Rep. 2008;10(4):304–310. doi: 10.1007/s11920-008-0049-7. [DOI] [PubMed] [Google Scholar]
  • 59.Heffner KL, Kiecolt-Glaser JK, Loving TJ, Glaser R, Malarkey WB. Spousal support satisfaction as a modifier of physiological responses to marital conflict in younger and older couples. Journal of Behavioral Medicine. 2004;27(3):233–254. doi: 10.1023/b:jobm.0000028497.79129.ad. [DOI] [PubMed] [Google Scholar]
  • 60.Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study. Cardiovasc Diabetol. 2006:5. doi: 10.1186/1475-2840-5-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Parkin DM. The global health burden of infection -associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–3044. doi: 10.1002/ijc.21731. [DOI] [PubMed] [Google Scholar]
  • 62.Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT. Social regulation of gene expression in human leukocytes. Genome Biol. 2007;8(9):R189. doi: 10.1186/gb-2007-8-9-r189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Creswell JD, Irwin MR, Burklund LJ, et al. Mindfulness-Based Stress Reduction training reduces loneliness and pro-inflammatory gene expression in older adults: A small randomized controlled trial. Brain Behav Immun. 2012;26(7):1095–1101. doi: 10.1016/j.bbi.2012.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Hackett RA, Hamer M, Endrighi R, Brydon L, Steptoe A. Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women. Psychoneuroendocrinology. 2012;37(11):1801–1809. doi: 10.1016/j.psyneuen.2012.03.016. [DOI] [PubMed] [Google Scholar]
  • 65.Kiecolt-Glaser JK, Dura JR, Speicher CE, Trask OJ, Glaser R. Spousal caregivers of dementia victims: Longitudinal changes in immunity and health. Psychosom Med. 1991;53(4):345–362. doi: 10.1097/00006842-199107000-00001. [DOI] [PubMed] [Google Scholar]
  • 66.Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA. 2003;100(15):9090–9095. doi: 10.1073/pnas.1531903100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Damjanovic AK, Yang Y, Glaser R, et al. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer’s disease patients. J Immunol. 2007;179(6):4249–4254. doi: 10.4049/jimmunol.179.6.4249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 1999;54(9):M434–439. doi: 10.1093/gerona/54.9.m434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Von Känel R, Dimsdale JE, Ancoli-Israel S, et al. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer’s disease. J Am Geriatr Soc. 2006;54(3):431–437. doi: 10.1111/j.1532-5415.2005.00642.x. [DOI] [PubMed] [Google Scholar]
  • 70.Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun. 2009;23(7):936–944. doi: 10.1016/j.bbi.2009.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med. 2003;65(3):347–356. doi: 10.1097/01.psy.0000041542.29808.01. [DOI] [PubMed] [Google Scholar]
  • 72.Kling MA, Alesci S, Csako G, et al. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins c-reactive protein and serum amyloid. Biol Psychiatry. 2007;62(4):309–313. doi: 10.1016/j.biopsych.2006.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Steptoe A, Wardle J, Pollard TM, Canaan L, Davies GJ. Stress, social support and health-related behavior: A study of smoking, alcohol consumption and physical exercise. J Psychosom Res. 1996;41(2):171–180. doi: 10.1016/0022-3999(96)00095-5. [DOI] [PubMed] [Google Scholar]
  • 74.Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med. 2002;64(3):418–435. doi: 10.1097/00006842-200205000-00006. [DOI] [PubMed] [Google Scholar]
  • 75.Miller AH. Depression and immunity: A role for T cells? Brain Behav Immun. 2010;24(1):1–8. doi: 10.1016/j.bbi.2009.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Irwin MR. Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun. 2008;22(2):129–139. doi: 10.1016/j.bbi.2007.07.013. [DOI] [PubMed] [Google Scholar]
  • 77.Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21(4):374–383. doi: 10.1016/j.bbi.2007.01.010. [DOI] [PubMed] [Google Scholar]
  • 78.Whisman MA, Uebelacker LA. Comorbidity of relationships distress and mental and physical health problems. In: Snyder DK, Whisman MA, editors. Treating Difficult Couples: Helping Clients with Coexisting Mental and Relationship Disorders. New York, NY: Guilford Press; 2003. pp. 3–26. [Google Scholar]
  • 79.Wirtz PH, Von Knel R, Emini L, Suter T, Fontana A, Ehlert U. Variations in anticipatory cognitive stress appraisal and differential proinflammatory cytokine expression in response to acute stress. Brain Behav Immun. 2007;21(6):851–859. doi: 10.1016/j.bbi.2007.02.003. [DOI] [PubMed] [Google Scholar]
  • 80.Carroll JE, Low CA, Prather AA, et al. Negative affective responses to a speech task predict changes in interleukin (IL)-6. Brain Behav Immun. 2011;25(2):232–238. doi: 10.1016/j.bbi.2010.09.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Song C, Kenis G, Van Gastel A, et al. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res. 1999;85(3):293–303. doi: 10.1016/s0165-1781(99)00012-8. [DOI] [PubMed] [Google Scholar]
  • 82.Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J. 2001;15(1):43–58. doi: 10.1096/fj.99-1003rev. [DOI] [PubMed] [Google Scholar]
  • 83.Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpé S. Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol Med. 2001;31(05):847–858. doi: 10.1017/s0033291701004007. [DOI] [PubMed] [Google Scholar]
  • 84.Fagundes CP, Glaser R, Hwang BS, Malarkey WB, Kiecolt-Glaser JK. Depressive symptoms enhance stress-induced inflammatory responses. [Accessed August 13, 2012];Brain Behav Immun. doi: 10.1016/j.bbi.2012.05.006. in press. Available at: http://www.sciencedirect.com/science/article/pii/S0889159112001134. [DOI] [PMC free article] [PubMed]
  • 85.Jaremka LM, Fagundes CP, Peng J, et al. Loneliness promotes inflammation during acute stress. Psychol Sci. doi: 10.1177/0956797612464059. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Kiecolt-Glaser JK, Gouin J-P, Hantsoo L. Close relationships, inflammation, and health. Neurosci Biobehav Rev. 2010;35(1):33–38. doi: 10.1016/j.neubiorev.2009.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: How hot is the link? Biochem Pharmacol. 2006;72(11):1605–1621. doi: 10.1016/j.bcp.2006.06.029. [DOI] [PubMed] [Google Scholar]
  • 88.Corren J. Anti-interleukin-5 antibody therapy in asthma and allerges. Curr Opin Allergy Clin Immunol. 2011;11(6):565–570. doi: 10.1097/ACI.0b013e32834c3d30. [DOI] [PubMed] [Google Scholar]
  • 89.Fitzgerald JE, Kreutzer DL. Localization of interleukin-8 in human gingival tissues. Oral Microbiology and Immunology. 1995;10(5):297–303. doi: 10.1111/j.1399-302x.1995.tb00158.x. [DOI] [PubMed] [Google Scholar]
  • 90.Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996;183(1):195–201. doi: 10.1084/jem.183.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–843. doi: 10.1056/NEJM200003233421202. [DOI] [PubMed] [Google Scholar]
  • 92.Kiecolt-Glaser JK, Glaser R. Depression and immune function: Central pathways to morbidity and mortality. J Psychosom Res. 2002;53(4):873–876. doi: 10.1016/s0022-3999(02)00309-4. [DOI] [PubMed] [Google Scholar]
  • 93.Hugo FN, Hilgert JB, Bozzetti MC, et al. Chronic stress, depression, and cortisol levels as risk indicators of elevated plaque and gingivitis levels in individuals aged 50 years and older. J Periodontol. 2006;77(6):1008–1014. doi: 10.1902/jop.2006.050037. [DOI] [PubMed] [Google Scholar]
  • 94.Johannsen A, Rydmark I, Söder B, Åsberg M. Gingival inflammation, increased periodontal pocket depth and elevated interleukin-6 in gingival crevicular fluid of depressed women on long-term sick leave. Journal of Periodontal Research. 2007;42(6):546–552. doi: 10.1111/j.1600-0765.2007.00980.x. [DOI] [PubMed] [Google Scholar]
  • 95.Johannsen A, Rylander G, Söder B, Asberg M. Dental plaque, gingival inflammation, and elevated levels of interleukin-6 and cortisol in gingival crevicular fluid from women with stress-related depression and exhaustion. J Periodontol. 2006;77(8):1403–1409. doi: 10.1902/jop.2006.050411. [DOI] [PubMed] [Google Scholar]
  • 96.LeResche L, Dworkin SF. The role of stress in inflammatory disease, including periodontal disease: Review of concepts and current findings. Periodontology. 2002;30(1):91–103. doi: 10.1034/j.1600-0757.2002.03009.x. [DOI] [PubMed] [Google Scholar]
  • 97.Vitaliano PP, Persson R, Kiyak A, Saini H, Echeverria D. Caregiving and gingival symptom reports: Psychophysiologic mediators. Psychosom Med. 2005;67(6):930–938. doi: 10.1097/01.psy.0000188485.65153.7b. [DOI] [PubMed] [Google Scholar]
  • 98.Weik U, Herforth A, Kolb-Bachofen V, Deinzer R. Acute stress induces proinflammatory signaling at chronic inflammation sites. Psychosom Med. 2008;70(8):906–912. doi: 10.1097/PSY.0b013e3181835bf3. [DOI] [PubMed] [Google Scholar]
  • 99.Giannopoulou C, Kamma JJ, Mombelli A. Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol. 2003;30(2):145–153. doi: 10.1034/j.1600-051x.2003.300201.x. [DOI] [PubMed] [Google Scholar]
  • 100.Deinzer R, Förster P, Fuck L, Herforth A, Stiller-Winkler R, Idel H. Increase of crevicular interleukin 1beta under academic stress at experimental gingivitis sites and at sites of perfect oral hygiene. J Clin Periodontol. 1999;26(1):1–8. doi: 10.1034/j.1600-051x.1999.260101.x. [DOI] [PubMed] [Google Scholar]
  • 101.Deinzer R, Kottmann W, Förster P, Herforth A, Stiller-Winkler R, Idel H. After-effects of stress on crevicular interleukin-1β. J Clin Periodontol. 2000;27(1):74–77. doi: 10.1034/j.1600-051x.2000.027001074.x. [DOI] [PubMed] [Google Scholar]
  • 102.Chandola T, Britton A, Brunner E, et al. Work stress and coronary heart disease: What are the mechanisms? Eur Heart J. 2008;29(5):640–648. doi: 10.1093/eurheartj/ehm584. [DOI] [PubMed] [Google Scholar]
  • 103.Frasure-Smith N, Lespérance F, Irwin MR, Sauvé C, Lespérance J, Théroux P. Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes. Biol Psychiatry. 2007;62(4):302–308. doi: 10.1016/j.biopsych.2006.09.029. [DOI] [PubMed] [Google Scholar]
  • 104.Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet. 2010;375(9709):132–140. doi: 10.1016/S0140-6736(09)61717-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation and incident cardiovascular disease in women with suspected coronary ischemia - The national heart, lung, and blood institute-sponsored WISE study. J Am Coll Cardiol. 2007;50(21):2044–2050. doi: 10.1016/j.jacc.2007.07.069. [DOI] [PubMed] [Google Scholar]
  • 106.World Health Organization. [Accessed September 5, 2012];Fact sheet: Obesity and overweight. 2012 Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
  • 107.Björntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obesity Reviews. 2001;2(2):73–86. doi: 10.1046/j.1467-789x.2001.00027.x. [DOI] [PubMed] [Google Scholar]
  • 108.Luppino FS, De Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–229. doi: 10.1001/archgenpsychiatry.2010.2. [DOI] [PubMed] [Google Scholar]
  • 109.Vogelzangs N, Kritchevsky SB, Beekman ATF, et al. Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 2008;65(12):1386–1393. doi: 10.1001/archpsyc.65.12.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Tilg H, Moschen AR. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772–783. doi: 10.1038/nri1937. [DOI] [PubMed] [Google Scholar]
  • 111.Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition. 2004;92(03):347–355. doi: 10.1079/bjn20041213. [DOI] [PubMed] [Google Scholar]
  • 112.Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9(1):88. doi: 10.1186/1471-2458-9-88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–1932. doi: 10.1016/j.jacc.2008.12.068. [DOI] [PubMed] [Google Scholar]
  • 114.Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741. doi: 10.1016/j.biopsych.2008.11.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. doi: 10.1038/nrn2297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Strike PC, Wardle J, Steptoe A. Mild acute inflammatory stimulation induces transient negative mood. J Psychosom Res. 2004;57(2):189–194. doi: 10.1016/S0022-3999(03)00569-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Wright CE, Strike PC, Brydon L, Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun. 2005;19(4):345–350. doi: 10.1016/j.bbi.2004.10.003. [DOI] [PubMed] [Google Scholar]
  • 118.Eisenberger NI, Inagaki TK, Mashal NM, Irvin MR. Inflammation and social experience: An inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav Immun. 2010;24(4):558–563. doi: 10.1016/j.bbi.2009.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58(5):445–452. doi: 10.1001/archpsyc.58.5.445. [DOI] [PubMed] [Google Scholar]
  • 120.Capuron L, Miller AH. Cytokines and psychopathology: Lessons from interferon-alpha. Biol Psychiatry. 2004;56(11):819–824. doi: 10.1016/j.biopsych.2004.02.009. [DOI] [PubMed] [Google Scholar]
  • 121.Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344(13):961–966. doi: 10.1056/NEJM200103293441303. [DOI] [PubMed] [Google Scholar]
  • 122.Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord. 2009;119(1–3):181–185. doi: 10.1016/j.jad.2009.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26(5):643–652. doi: 10.1016/S0893-133X(01)00407-9. [DOI] [PubMed] [Google Scholar]
  • 124.McNutt MD, Liu S, Manatunga A, et al. Neurobehavioral effects of interferon-α in patients with hepatitis-C: Symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacology. 2012;37(6):1444–1454. doi: 10.1038/npp.2011.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. The Lancet. 2006;367(9504):29–35. doi: 10.1016/S0140-6736(05)67763-X. [DOI] [PubMed] [Google Scholar]
  • 126.DellaGioia N, Hannestad J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev. 2010;34(1):130–143. doi: 10.1016/j.neubiorev.2009.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Lanquillon S, Krieg J-C, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22(4):370–379. doi: 10.1016/S0893-133X(99)00134-7. [DOI] [PubMed] [Google Scholar]
  • 128.O’Brien SM, Scott LV, Dinan TG. Antidepressant therapy and C-reactive protein levels. Br J Psychiatry. 2006;188:449–452. doi: 10.1192/bjp.bp.105.011015. [DOI] [PubMed] [Google Scholar]
  • 129.Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr. 2010;91(3):757–770. doi: 10.3945/ajcn.2009.28313. [DOI] [PubMed] [Google Scholar]
  • 130.Lin P-Y, Su K-P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056–1061. doi: 10.4088/jcp.v68n0712. [DOI] [PubMed] [Google Scholar]
  • 131.Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial. Brain Behav Immun. 2012;26(6):988–995. doi: 10.1016/j.bbi.2012.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R. Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Brain Behav Immun. 2011;25(8):1725–1734. doi: 10.1016/j.bbi.2011.07.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Pace TWW, Negi LT, Adame DD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology. 2009;34(1):87–98. doi: 10.1016/j.psyneuen.2008.08.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Kiecolt-Glaser JK, Christian L, Preston H, et al. Stress, inflammation, and yoga practice. Psychosom Med. 2010;72(2):113–121. doi: 10.1097/PSY.0b013e3181cb9377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11(9):607–615. doi: 10.1038/nri3041. [DOI] [PubMed] [Google Scholar]
  • 136.Herring MP, Puetz TW, O’Connor PJ, Dishman RK. Effect of exercise training on depressive symptoms among patients with a chronic illness: A systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(2):101–111. doi: 10.1001/archinternmed.2011.696. [DOI] [PubMed] [Google Scholar]
  • 137.Hoffman BM, Babyak MA, Craighead WE, et al. Exercise and pharmacotherapy in patients with major depression: One-year follow-up of the SMILE study. Psychosom Med. 2011;73(2):127–133. doi: 10.1097/PSY.0b013e31820433a5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Baumeister RF, Leary MR. The need to belong: Desire for interpersonal attachments as a fundamental human motivation. Psychological Bulletin. 1995;117(3):497–529. [PubMed] [Google Scholar]
  • 139.Hawkley LC, Cacioppo JT. Loneliness matters: A theoretical and empirical review of consequences and mechanisms. Ann Behav Med. 2010;40(2):218–227. doi: 10.1007/s12160-010-9210-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Markus HR, Kitayama S. Culture and the self: Implications for cognition, emotion, and motivation. Psychological Review. 1991;98(2):224–253. [Google Scholar]
  • 141.Bodnar JC, Kiecolt-Glaser JK. Caregiver depression after bereavement: Chronic stress isn’t over when it’s over. Psychol Aging. 1994;9(3):372–380. doi: 10.1037//0882-7974.9.3.372. [DOI] [PubMed] [Google Scholar]
  • 142.Kiecolt-Glaser JK, Glaser R. Stress and immunity: Age enhances the risks. Current Directions in Psychological Science. 2001;10(1):18–21. [Google Scholar]
  • 143.Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health. Psychol Bull. 1996;119(3):488–531. doi: 10.1037/0033-2909.119.3.488. [DOI] [PubMed] [Google Scholar]
  • 144.Rector NA, Roger D. The stress buffering effects of self-esteem. Personality and Individual Differences. 1997;23(5):799–808. [Google Scholar]
  • 145.Ford MB, Collins NL. Self-esteem moderates neuroendocrine and psychological responses to interpersonal rejection. Journal of Personality and Social Psychology. 2010;98(3):405–419. doi: 10.1037/a0017345. [DOI] [PubMed] [Google Scholar]
  • 146.Appelhans BM, Whited MC, Schneider KL, et al. Depression severity, diet quality, and physical activity in women with obesity and depression. J Acad Nutr Diet. 2012;112(5):693–698. doi: 10.1016/j.jand.2012.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Kiecolt-Glaser JK. Stress, food, and inflammation: Psychoneuroimmunology and nutrition at the cutting edge. Psychosom Med. 2010;72(4):365–369. doi: 10.1097/PSY.0b013e3181dbf489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003;65(4):571–581. doi: 10.1097/01.psy.0000074003.35911.41. [DOI] [PubMed] [Google Scholar]

RESOURCES